Skip to main navigation Skip to search Skip to main content

Immune response in mice immunized with chimeric H1 antigens

  • Erasmus Nikoi Kotey
  • , William Kwabena Ampofo
  • , Rebecca Daines
  • , Jean Remy Sadeyen
  • , Munir Iqbal
  • , Osbourne Quaye
  • University of Ghana
  • The Pirbright Institute
  • Royal Veterinary College University of London

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Abstract

Identification of a universal influenza vaccine candidate has remained a global challenge for both humans and animals. This study describes an approach that uses consensus sequence building to generate chimeric HAs (cHAs): two resultant H1 HA-based chimeras comprising of conserved sequences (within several areas spanning the head and stalk regions) of H1 and H5 or H9 HAs. These cHAs expressed in Drosophila cells (S2) were used to immunize mice. All immunized mice were protected from an infectious H1 virus challenge. Seroconverted mice sera to the H1 cHAs inhibited both the challenge virus and an H5 virus isolate by haemagglutination inhibition (HI) assay. These findings further emphasize that cHAs induce cross-reactive antibodies against conserved areas of both head and stalk regions of the seasonal influenza A (H1N1) pdm09 virus’ HA and holds potential for further development of a universal influenza vaccine.

Original languageEnglish
Article number1182
JournalVaccines
Volume9
Issue number10
DOIs
Publication statusPublished - Oct 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Broad-reactive antibodies
  • Chimeric haemagglutinin
  • Cross-reactivity
  • Prophylactic
  • Seasonal influenza
  • Therapeutic
  • Universal influenza vaccine

Fingerprint

Dive into the research topics of 'Immune response in mice immunized with chimeric H1 antigens'. Together they form a unique fingerprint.

Cite this